Time to Reconsider Utah Medical Products Inc (NASDAQ:UTMD) After More Short Sellers?

Investors sentiment decreased to 1.29 in Q4 2018. Its down 0.63, from 1.92 in 2018Q3. It is negative, as 11 investors sold Utah Medical Products, Inc. shares while 24 reduced holdings. 16 funds opened positions while 29 raised stakes. 2.66 million shares or 0.24% less from 2.67 million shares in 2018Q3 were reported.
Prudential accumulated 0% or 6,186 shares. Citigroup Inc reported 842 shares stake. Pnc Fincl Ser Gru Incorporated has 306 shares for 0% of their portfolio. Plante Moran Financial Advsrs Ltd Company holds 0% or 9 shares. Ancora Advsrs Ltd invested in 0.3% or 75,482 shares. Royal Bank & Trust Of Canada reported 1,000 shares stake. Fmr Ltd Liability Co reported 477,007 shares. Moreover, Barclays Public Ltd Com has 0% invested in Utah Medical Products, Inc. (NASDAQ:UTMD). Bessemer Grp Incorporated Incorporated stated it has 0% of its portfolio in Utah Medical Products, Inc. (NASDAQ:UTMD). Jpmorgan Chase & Communication owns 24,218 shares. Deutsche Bank & Trust Ag holds 0% or 4,691 shares. Massachusetts-based Rhumbline Advisers has invested 0% in Utah Medical Products, Inc. (NASDAQ:UTMD). 9 are owned by Cwm Ltd Limited Liability Company. Us Retail Bank De holds 0% in Utah Medical Products, Inc. (NASDAQ:UTMD) or 10,466 shares. 136 were accumulated by Bnp Paribas Arbitrage.

Since November 27, 2018, it had 0 insider buys, and 2 sales for $330,923 activity.

The stock of Utah Medical Products Inc (NASDAQ:UTMD) registered an increase of 3.66% in short interest. UTMD’s total short interest was 42,500 shares in May as published by FINRA. Its up 3.66% from 41,000 shares, reported previously. With 11,200 shares average volume, it will take short sellers 4 days to cover their UTMD’s short positions. The short interest to Utah Medical Products Inc’s float is 1.33%.

The stock decreased 0.52% or $0.45 during the last trading session, reaching $86.15. About 18,106 shares traded or 28.75% up from the average. Utah Medical Products, Inc. (NASDAQ:UTMD) has risen 0.29% since May 15, 2018 and is uptrending. It has underperformed by 4.08% the S&P500.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide. The company has market cap of $320.71 million. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It has a 18.33 P/E ratio. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

More notable recent Utah Medical Products, Inc. (NASDAQ:UTMD) news were published by: Seekingalpha.com which released: “23 Upcoming Dividend Increases – Seeking Alpha” on December 06, 2018, also Globenewswire.com with their article: “Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2019 – GlobeNewswire” published on April 25, 2019, Gurufocus.com published: “Apr 10, 2019 – Riverview Trust Co Buys iShares Russell Mid-cap Value, iShares Russell 2000, iShares Short Treasury Bond ETF, Sells iShares Core US Aggregate Bond, SPDR Series Trust Portfolio S&P 500 Growth, iShares Edge MSCI USA Momentum Factor – GuruFocus.com” on April 10, 2019. More interesting news about Utah Medical Products, Inc. (NASDAQ:UTMD) were released by: Finance.Yahoo.com and their article: “Discount travel website promises cheapest flights anywhere – Yahoo Finance” published on May 16, 2018 as well as Seekingalpha.com‘s news article titled: “Utah Medical Products declares $0.275 dividend – Seeking Alpha” with publication date: May 07, 2019.

Utah Medical Products, Inc. (NASDAQ:UTMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.